11 C](R)-PK11195 is a marker of activated microglia, which can be used to measure inflammation in neurologic disorders. The purpose of the present study was to define the optimal reference tissue model based on a comparison with a validated plasma input model and using clinical studies and Monte Carlo simulations. Accuracy and reproducibility of reference tissue models were evaluated using Monte Carlo simulations. The effects of noise and variation in specific binding, nonspecific binding and blood volume were evaluated. Dynamic positron emission tomography scans were performed on 13 subjects, and radioactivity in arterial blood was monitored online. In addition, blood samples were taken to generate a metabolite corrected plasma input function. Both a (validated) two-tissue reversible compartment model with K 1 /k 2 fixed to whole cortex and various reference tissue models were fitted to the data. Finally, a simplified reference tissue model (SRTM) corrected for nonspecific binding using plasma input data (SRTM pl_corr ) was investigated. Correlations between reference tissue models (including SRTM pl_corr ) and the plasma input model were calculated. Monte Carlo simulations indicated that low-specific binding results in decreased accuracy and reproducibility. In this respect, the SRTM and SRTM pl_corr performed relatively well. Varying blood volume had no effect on performance. In the clinical evaluation, SRTM pl_corr and SRTM had the highest correlations with the plasma input model (R 2 = 0.82 and 0.78, respectively). SRTM pl_corr is optimal when an arterial plasma input curve is available. Simplified reference tissue model is the best alternative when no plasma input is available.
Introduction
Carbon-11 labeled (R)-PK11195 ((R)-1-(2-chlorophenyl)-N-[ 11 C]methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide) is a ligand for the peripheral benzodiazepine receptor. In the brain, this receptor is mainly expressed on activated microglia (Banati et al, 1997) . Both [ 11 C](R)-PK11195 and [ 11 C]PK11195 have been used as positron emmision tomography (PET) tracers to study activated microglia in various neurologic disorders. It has been used to study stroke (Ramsay et al, 1992; Pappata et al, 2000; Gerhard et al, 2000 Gerhard et al, , 2005a , Alzheimer's disease (Groom et al, 1995; Cagnin et al, 2001a; Versijpt et al, 2003) , multiple sclerosis (Banati et al, 2000; Debruyne et al, 2002 Debruyne et al, , 2003 Versijpt et al, 2005) and various other diseases (Pappata et al, 1991; Banati et al, 1999 Banati et al, , 2001 Goerres et al, 2001; Cagnin et al, 2001b Cagnin et al, , 2004 Cicchetti et al, 2002; Gerhard et al, 2003 Gerhard et al, , 2004 Gerhard et al, , 2005b Turner et al, 2004 Turner et al, , 2005 Venneti et al, 2004; Henkel et al, 2004; Ouchi et al, 2005) . Most studies have used a reference tissue approach to quantify binding, either by applying the simplified reference tissue model (SRTM) (Lammertsma and Hume, 1996) or by using uptake normalized to a reference region. The use of a reference tissue approach, however, has not been validated for [ 11 C](R)-PK11195. This validation requires comparison with a plasma input model. Recently, we have shown that a two-tissue reversible model with fixed K 1 /k 2 is optimal for [ 11 C](R)-PK11195 studies using a plasma input function (Kropholler et al, 2005) .
The purpose of the present study was to determine the optimal reference tissue model by comparing various reference tissue models with this plasma input model.
Materials and methods

Overview of Kinetic Models
In total, nine models, in which a reference tissue was used, were evaluated. The main characteristics of the models are shown in Table 1 . A more detailed description of these models is given in Appendix A. Five of these models were true reference tissue models, in that the reference tissue curve was used as the input function. These models were:
A. SRTM (Lammertsma and Hume, 1996) . B. Full reference tissue model (FRTM) (Hume et al, 1992) . C. Reference tissue model with two target and two reference tissue compartments (R 2T2R ). D. As R 2T2R , but with the same k 4 for target and reference tissues, that is,
). E. Reference tissue model with three target and two reference tissue compartments, and with the same k 5 and k 6 for both tissues, that is, k 5 = k 5 0 and k 6 = k 6 0 (R k5k6 3T2R ).
In two models (specific) binding potential (BP sp ) was obtained indirectly through BP sp = (V d ÀV d 0 )/V d 0 , in which the volumes of distribution for target (V d ) and reference (V d 0 ) tissues were obtained from plasma input fits:
F. Indirect plasma input model with two target and one reference tissue compartments (VD 2T1R ). G. Indirect plasma input model with two target and two reference tissue compartments (VD 2T2R ) (Lammertsma et al, 1996a ).
In one model BP sp was obtained by subtracting total binding potential of the reference (nonspecific) from that of the target (specific + nonspecific) tissue. These total binding potentials were obtained from plasma input fits:
H. Plasma input model with two target and two reference tissue compartments using subtraction of binding potentials (SUB 2T2R ).
In the final model BP sp as obtained from SRTM (BP SRTM ) was corrected for the contribution of nonspecific binding potential (BP ns ), according to BP sp = BP SRTM Á (1 + BP ns ). Here, BP ns was obtained from a plasma input fit of the reference tissue:
I. Simplified reference tissue model corrected for nonspecific binding using a plasma input model with two compartments for the reference tissue (SRTM pl_corr ).
Two plasma input models were used in this study. One model was used for comparison with the reference tissue models. This model was a two-tissue reversible compartment model with the K 1 /k 2 ratio fixed to the value obtained for whole cortex. In a previous study, it was demonstrated that this is the optimal plasma input model for [ 11 C](R)-PK11195 studies (Kropholler et al, 2005) . The other plasma input model was a three-tissue compartment model with different compartments for specific and nonspecific binding (Gunn et al, 2001) and was used to generate tissue time-activity curves (TACs) for the Monte Carlo simulations.
Monte Carlo Simulations
A typical plasma [ 11 C](R)-PK11195 TAC was used as input function for the Monte Carlo simulations. Tissue TACs were generated using the three-tissue compartment model. Values for the various model parameters were based on clinical data: K 1 = 0.05 ml mins À1 ml À1 , k 2 = 0.15 mins À1 , k 4 = 0.2 mins À1 , BP sp = 0.5, k 6 = 0.04 mins À1 , BP ns = 1.5 and blood volume V b = 7%. Uniform Gaussian noise was used ), indirect estimates of BP using plasma input estimates of V d (VD 2T1R , VD 2T2R ) or total binding potential (SUB 2T2R ) and methods using a combination of plasma and reference inputs (SRTM pl_corr ).
with a coefficient of variation (COV) of 7.5%. Simulations were performed with parameters fixed at the correct value and with parameters varied over a physiologic range. Specific binding potential (BP sp ) was varied between 0 and the maximum value of 1 observed in clinical data. Ranges for BP ns and V b were set at 710% and 716%, respectively, based on previously published subject data (Kropholler et al, 2005) . Noise was varied between 0% and 10% COV. When BP sp , BP ns or V b was varied, each reported result was based on 500 simulations. When parameters were fixed at the correct value, 3000 simulations were performed.
Accuracy and reproducibility of BP sp were calculated with accuracy expressed as percentage bias and reproducibility as the COV.
Clinical Evaluation
Subjects: Five subjects with traumatic brain injury (five males, mean age7s.d. = 39717 years), scanned 2872 weeks after trauma, and eight elderly healthy subjects (eight males, age 6778 years) were included in the study. These two subject groups were selected in order to be able to evaluate the various models over the full range of microglia activation seen in clinical practice. The study was approved by the medical ethics committee of the VU University Medical Centre. All subjects gave informed consent before inclusion. In the present study, clinical data were used only for model comparison. Clinical interpretation of the results in these subjects is beyond the scope of the present study and will be reported elsewhere.
Scanning protocol: Studies were performed in 3D acquisition mode using an ECAT Exact HR + scanner (CTI/Siemens, Knoxville, TN, USA). Characteristics of this scanner have been described elsewhere (Brix et al, 1997; Adam et al, 1997) . Before tracer administration, a 10 mins transmission scan was performed, which was used to correct the subsequent emission scans for attenuation. First, a [ 15 O]H 2 O emission scan was performed, but this scan was not used in the present study. Next, A 1-h dynamic [ 11 C](R)-PK11195 emission scan was performed. Time frames used for the [ 11 C](R)-PK11195 scan were 1 Â 30, 1 Â 15, 1 Â 5, 1 Â 10, 2 Â 15, 2 Â 30, 3 Â 60, 4 Â 150, 5 Â 300 and 2 Â 600 secs. The first frame was used to correct for possible background radioactivity resulting from the previous [ 15 O]H 2 O scan. 328795 MBq [ 11 C](R)-PK11195 with a specific activity of 83723 GBq/mmol at end of synthesis was administered as a bolus simultaneously with the start of the second frame. A neuro-insert (CTI/Siemens, Knoxville, TN, USA) was used to reduce the contribution of scattered photons. Arterial blood was withdrawn continuously using an online blood-sampling device described previously (Boellaard et al, 2001) . At 3, 5, 10, 20, 30, 40 and 60 mins after tracer injection blood sampling was interrupted briefly for withdrawal of manual samples, followed by flushing of the arterial line with heparinised saline. Plasma and whole-blood activity were measured and metabolite levels in plasma were determined using HPLC as described previously (Greuter et al, 2004) .
In addition, T1 weighted magnetic resonance imaging (MRI) scans were acquired using a 1 T IMPACT scanner (Siemens Medical Solutions, Erlangen, Germany).
Image reconstructions: All emission scans were normalized and corrected for attenuation, randoms, dead time, scatter and decay. Emission scans were reconstructed using filtered backprojection and a Hanning filter with a cutoff of 0.5 times the Nyquist frequency, resulting in a spatial resolution of approximately 7 mm full-width at half-maximum at the center of the field of view. A zoom factor of two and a matrix size of 256 Â 256 Â 63 were used resulting in a voxel size of 1.2 Â 1.2 Â 2.4 mm 3 .
Image analysis: The skull was removed from the MRI scans using a brain extraction tool (Smith, 2002) , which is part of the FMRIB software library (www.fmrib.ox.ac.uk/ fsl, Image analysis group, Oxford, UK). Deskulled brain and corresponding PET scans were aligned using a mutual information algorithm included in the image registration package MIRIT West et al, 1997) . Correct alignment was checked visually.
For trauma patients, a voxel-by-voxel Logan plot (Logan, 2000) was performed to obtain an initial overview of regions with high and low binding. Next, these V d images were used to draw regions of interest (ROIs). The thalamus was found to have high V d and was used as target ROI. In this group, a large cortical region with low V d was used as a reference tissue ROI. For patients suffering from neurotrauma activation of microglia and thus elevated [ 11 C](R)-PK11195 binding might have been present in the cerebellum as well. By defining a ROI on initial estimates of [ 11 C](R)-PK11195 binding it was attempted to obtain a reference tissue curve with minimal or no increased [ 11 C](R)-PK11195 binding. Moreover, patient head motion during scanning could not be avoided for this specific patient group and by defining a large cortical ROI with low uptake, the effects of patient motion on the quality of the reference tissue TAC was further minimized. Note that even with this strategy, it is not guaranteed that the reference tissue was free of activated microglia, but binding in these reference tissues turned out to be sufficiently low to study relative increases of [ 11 C](R)-PK11195 binding in the thalamus and it did not systematically effect the (inter-)comparison of reference tissue models against plasma input data.
For the control group of healthy elderly subjects, there is increased microglia activation in the thalamus (Cagnin et al, 2001a) . This region has been drawn as target ROI. The cerebellum was used as a reference tissue region for elderly subjects, assuming low or no specific binding in this area, as was also performed by other investigators (Gerhard et al, 2005a) , although use of the cerebellum as reference is still a matter of debate.
Kinetic analysis: Kinetic modeling was performed using dedicated software developed within matlab 5.3 (The Mathworks, Natick, MA, USA). A metabolite corrected plasma input function was generated as described previously (Kropholler et al, 2005) . Separate input functions for whole blood (to estimate V b ) and metabolite corrected plasma concentrations were used in all (plasma input) fits. Delay between injection and arrival of the [ 11 C](R)-PK11195 bolus was estimated by fitting a reversible two-tissue compartment model, including V b and delay to the subjects' whole-cortex TAC. Delay was then fixed to this value for all other ROIs.
Target ROIs were fitted to the various reference tissue based models. In addition, ROIs were fitted to the twotissue reversible plasma input compartment model with K 1 /k 2 fixed to the cortical value. Correlations between this plasma input model and the various reference tissue based models were evaluated.
Results
Monte Carlo Simulations
Biases of the reference tissue models, when all parameters were set to the true values and at 0% noise level, are shown in Table 2 . In addition, bias and COV for 10% noise level are given. Several models showed considerable bias, notably SRTM, FRTM and VD 2T2R , and for the 10% noise level R 2T2R and R k5k6 3T2R . Coefficient of variation was very high for models R 2T2R , VD 2T2R and SUB 2T2R .
All models showed relatively constant BP sp with varying noise levels, except for R 2T2R and R k5k6 3T2R , which both showed large (B100%) variation in bias ( Figure 1A ). Coefficient of variation increased with increasing noise level, especially for models R 2T2R , VD 2T2R and SUB 2T2R ( Figure 1B) . Models SRTM, FRTM, R k4 2T2R , SRTM pl_corr all performed well with a maximum COV between 25 and 30%.
All models except SRTM and VD 2T2R showed large variations in bias when BP sp became small ( Figure  2A ). This was especially the case for R k5k6 3T2R , R k4 2T2R and VD 2T1R with biases larger than 100%. Coefficient of variation also became large in the case of small BP sp ( Figure 2B ). Here, VD 2T1R performed best with a COV of 37% at low BP sp , while COV became approximately 80% for SRTM and SRTM pl_corr . For all other models, COV became much larger than 100%.
Coefficient of variation for R k5k6
3T2R is outside the scale and therefore not visible in Figure 2B . Simulations were performed with parameters fixed to the correct value. 3000 runs were performed per value. 
Models R k4
2T2R , SUB 2T2R and SRTM pl_corr had little or no bias with varying BP ns ( Figure 2C ). All other models showed considerable bias. For all models, COV increases with increasing BP ns ( Figure 2D ). The increase was especially large for R 2T2R (not visible, COV > 100%), R k5k6 3T2R , VD 2T2R and SUB 2T2R and smallest for SRTM pl_corr .
Varying V b did not change bias of the models ( Figure  2E ). In addition, increasing V b did not result in a change in observed COV, except for R k5k6 3T2R ( Figure 2F ). 
Clinical Evaluation
Occasionally, some of the reference tissue models provided unrealistic BP sp . These poor fits mainly occurred for models with high number of fit parameters. These results were excluded from the analysis. For reference models with a low number of fit parameters, such as SRTM and SRTM pl_corr , no poor fits were observed. Correlation coefficients of the regressions between the two-tissue reversible plasma input model with K 1 /k 2 fixed to whole cortex and the reference tissue models are shown in Table  3 . Scatter plots between plasma input and reference tissue BP for the best reference tissue models are shown in Figure 3 . Note that the errors in SRTM pl_corr were calculated assuming no correlation between BP sp and BP ns , which is strictly not valid. The SRTM pl_corr model performs best, followed by SRTM and FRTM. The indirect methods (VD 2T1R and VD 2T2R ) and especially the direct reference tissue models R k5k6 3T2R and R 2T2R did not perform very well.
Discussion
Monte Carlo Simulations
When evaluating the results from the simulations, SRTM performed equally well or better than FRTM in all aspects. When the correct parameter values were used in the simulations, all models show bias at the 10% noise level (Table 2) . For SRTM (and FRTM), a bias of approximately 1/(1 + BP ns ) is expected because of the nonspecific binding. Bias, however, is acceptable if it remains relatively constant under physiologic variation between region and subjects. In contrast, large COV, as observed in R 2T2R , VD 2T2R and SUB 2T2R (B100% or more), seriously limits applicability.
As noise levels vary and, to a large degree, are unknown, bias for a good reference tissue model should be insensitive to changes in noise level. Models R 2T2R and R k5k6 3T2R showed biases that were very Figure 3 Correlations between binding potential calculated using various reference tissue models and the two-tissue reversible plasma input model with K 1 /k 2 fixed to the whole cortex value. Results are shown from neurotrauma subjects (&) and from elderly normal controls (n). Only results for models with a correlation coefficient of more than 0.7 are shown. dependent on noise level ( Figure 1A) , limiting their applicability in clinical studies. Measuring small BP sp with high accuracy and reproducibility proved to be difficult (Figures 2A  and 2B ). This is expected as it is difficult to distinguish a small specific signal from the much larger nonspecific signal. Both SRTM and SRTM pl_corr performed relatively well here, although increase in bias for SRTM pl_corr was substantial. The results for small BP sp seriously limit the applicability of models VD 2T2R and SUB 2T2R (high COV), VD 2T1R (high bias), and R 2T2R , R k4 2T2R and R k5k6 3T2R (high bias and COV).
For several models (SRTM, R 2T2R , R k4 2T2R , VD 2T1R and VD 2T2R ), the change in bias because of variations in BP ns was smaller ( Figure 2C ) than the change caused by variation in BP sp , and therefore less important in model evaluation. Increased COV with increasing BP ns ( Figure 2D ) for R k5k6 3T2R , VD 2T2R and SUB 2T2R is a serious limitation of these models.
Varying V b had little effect on bias and COV. For R k5k6 3T2R , increasing V b resulted in a substantial, but acceptable increase in COV.
Clinical Evaluation
In general, correlations between reference tissue model BPs and plasma input BPs were low due to both high noise levels in [ 11 C](R)-PK11195 studies (low uptake and high nonspecific binding) and different effects of nonspecific binding on plasma input and reference tissue models.
Only correlations for SRTM pl_corr , SRTM and FRTM were acceptable. The poor performance of R 2T2R , R k5k6 3T2R and to a lesser degree R k4 2T2R is probably due to the increased number of fitting parameters. The model SUB 2T2R suffers from an increase in COV because BP sp is calculated by subtracting two fitted parameters (of similar magnitude) with resulting error propagation. Similarly, models VD 2T2R and VD 2T1R also calculated BP sp by combining two V d values of similar magnitude resulting in unfavorable error propagation, explaining the poor correlations for these models ( Table 2) .
The results indicate that SRTM BP sp correlate well with plasma input BPs. From a theoretical point of view, a perfect correlation is not expected because the plasma input model measures the sum of BP sp and BP ns while SRTM measures specific BP alone. Since nonspecific binding is high (for subjects with neurotraumatic injury, plasma input BPs are in the order of B2 while SRTM BPs are B0.5), the plasma input model cannot be treated as the golden standard. The influence of BP ns on the calculated BP sp using reference tissue models will further decrease the reproducibility of measured BP sp (due to the bias of 1/(1 + BP ns ) in BP sp ) and to a lesser extend for SRTM pl_corr . Therefore, SRTM pl_corr is an improvement over SRTM. However, by including a correction for nonspecific binding, systematic and statistical errors in metabolite corrections might result in errors and increased uncertainties in observed specific binding using SRTM pl_corr .
Limitations
The reference tissues used in this study were cerebellum for the elderly healthy subjects and an (apparently) unaffected cortical region for neurotrauma patients. The cerebellum has been used previously (Groom et al, 1995; Banati et al, 1999; Versijpt et al, 2003; Gerhard et al, 2005a) , while an unaffected region was chosen to approximate those areas that would be found by cluster analysis as used in several reports (Banati et al, 2000 (Banati et al, , 2001 Cagnin et al, 2001a, b; Gerhard et al, 2003; Turner et al, 2004) . Both these reference regions might, however, not be 'perfect' as reference tissue, because increased specific binding in these structures cannot be excluded. Increased specific binding in the reference tissue would results in an underestimation of specific binding in the target areas. As in all models, the same reference region was used, possible presence of (a small degree of) specific binding in the reference region will only have a small effect on the comparisons based on the clinical data. For clinical data, the observed correlations between plasma input and reference tissue models could be reduced because of specific binding in the reference tissue, but it should affect all reference tissue models to a similar extent. Therefore, it should still be possible to identify the optimal reference tissue model.
The present study was not concerned with identifying the 'best' reference tissue. Further studies are required to identify optimal reference tissues for different clinical conditions (stroke, Alzheimer, neurotrauma, etc) . In addition, further studies are needed to assess methods that enable automatic extraction of reference tissue curves (e.g. cluster analysis).
General Conclusion
In this study, several reference tissue models were evaluated using both Monte Carlo simulations and clinical data. Among these models, SRTM pl_corr and SRTM performed best both in Monte Carlo simulations and in a clinical evaluation. Simplified reference tissue model does not require a metabolite corrected plasma input curve, and is therefore recommended for studies when only a reference tissue input is available. SRTM pl_corr , in which a correction for bias due to nonspecific binding is performed, performs better than SRTM, especially when measuring low BP sp . It has the advantage over the two-tissue reversible compartment model with K 1 /k 2 fixed to whole cortex that it measures BP sp instead of the sum of BP sp and BP ns which is very relevant for [ 11 C](R)-PK11195 as it is a tracer with large BP ns . Therefore, SRTM pl_corr is recommended for analyzing [ 11 C](R)-PK11195 studies when a metabolite corrected plasma input curve is available, while SRTM is recommended when only a reference tissue input can be used. reference tissue compartments are C t ðtÞ ¼ HðtÞ C r ðtÞ
In these equations, R1 = K 1 /K 1 0 and C r (t) the concentration in the reference tissue. The various F i and y i are functions of the kinetic parameters. If the plasma input transfer functions for the target and reference regions are H TP (s) and H RP (s), respectively, then the plasma input transfer function for the reference tissue model H TR (s) is (Gunn et al, 2001 As the target tissue contains three compartments and the reference tissue two, the final reference tissue model has five compartments. Substituting the transfer functions for the two tissues into the equation above results in
Next, F i TR and Y i TR , iA{1, 2, 3, 4}, will be expressed as a function of F j TP , Y j TP , F k TR and Y k TR of the original plasma input models. Both the left-and right-hand side of the equation above must have poles at s = ÀY i TR , iA{1, 2, 3, 4}. If all poles are unique, then it can be assumed without loss of generality that y TR i ¼ y TP i ; i 2 f1; 2; 3g 3T2R , derived from R 3T2R , assume a constant K 1 /k 2 ratio between target and reference tissues (i.e. k 2 0 = k 2 Á K 1 0 /K 1 = k 2 /R 1 ). Model R k5k6 3T2R also assumes that the kinetics of nonspecific binding are the same in reference and target regions. Expressions for R k5k6 3T2R can be derived by substituting k 2 0 by k 2 /R 1 , k 5 0 by k 5 and k 6 0 by k 6 . The fitted parameters for this model are R 1 , k 2 , BP sp , k 4 , BP ns and k 6 . Model R 2T2R can be derived by reducing the target tissue with one compartment and again by assuming a constant K 1 /k 2 ratio for target and reference tissues. The fitted parameters for this model are R 1 , k 2 , BP sp , k 4 , BP ns and k 6 0 . BP ns equals k 5 0 /k 6 0 and BP sp equals k 3 /k 4 -k 5 0 /k 6 0 . The equations for R 2T2R can be derived by substituting k 2 0 by k 2 /R 1 , by setting k 5 to zero and by neglecting k 6 . Model R k4 2T2R can be derived from R 2T2R by renaming k 5 0 to k 3 0 , k 6 0 to k 4 0 and by fitting k 4 0 and k 4 by a common parameter. The fitted parameters for this model are R1, k 2 , BP sp , BP ns and k 4 . The equations for this model can be derived by replacing k 6 0 by k 4 in the model R 2T2R . Model VD 2T2R uses a two-tissue reversible compartment model for both target and reference regions. Like all other plasma input models used in the present study, it includes a blood compartment and uses different time activity curves for blood and (metabolite corrected) plasma concentrations. The standard two-tissue reversible compartment model was used for the reference region. A modified two-tissue reversible compartment model with the K 1 /k 2 ratio fixed to the ratio of the reference tissue was used for the target region as described previously (Kropholler et al, 2005) . The BP sp is then estimated indirectly using BP sp = V d /(V d 0 ÀV d 0 ), in which V d is K 1 /k 2 (1 + k 3 /k 4 ) and V d 0 is defined correspondingly. The fitted parameters for this model are K 1 , k 2 , k 4 , BP and V b for the target region and K 1 0 , k 6 0 , BP and V b 0 for the reference region. Model VD 2T1R uses a one-tissue compartment model for the reference region, a two-tissue reversible compartment model for the target region and the same formula BP sp = V d /(V d 0 -V d 0 ). For the one-tissue reference region, V d 0 = K 1 0 /k 2 0 . The fitted parameters for this model are K 1 , k 2 , k 4 , BP and V b for the target region and K 1 0 , k 2 0 and V b 0 for the reference region. The model SUB 2T2R uses the same plasma input models as VD 2T2R but calculates BP sp by subtracting the estimated BP of the reference region from the BP of the target region.
The simplified reference tissue model corrected for nonspecific binding, SRTM pl_corr , estimates BP ns using the two-tissue reversible compartment model with plasma input and BP sp using SRTM (Lammertsma et al, 1996b) . The specific binding potential is then corrected for nonspecific binding using the equation BP sp = BP sp SRTM Á (1 + BP ns ) where BP sp SRTM is BP sp calculated using SRTM.
